Evidence map›Paper›PMID 33863277›Full record

ArticleJournal of neurodevelopmental disorders2021

Social cognition in 22q11.2 deletion syndrome and idiopathic developmental neuropsychiatric disorders.

Rhideeta Jalal, Aarti Nair, Amy Lin, Ariel Eckfeld, Leila Kushan, Jamie Zinberg, Katherine H Karlsgodt, Tyrone D Cannon, Carrie E Bearden

Open access · goldAbstract read
In one paragraph

Article in Journal of neurodevelopmental disorders, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Distinct neurocognitive profiles and clinical phenotypes associated with copy number variation at the 22q11.2 locus.Autism research : official journal of the International Society for Autism Research · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Rhideeta Jalal *Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA, USA.
Aarti Nair *Department of Psychology, Loma Linda University, Loma Linda, CA, USA. aartinair@gmail.com.ORCID 0000-0002-4058-6857
Amy LinDepartment of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA, USA.
Ariel EckfeldDepartment of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA, USA.
Leila KushanDepartment of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA, USA.
Jamie ZinbergDepartment of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA, USA.
Katherine H KarlsgodtDepartment of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA, USA.
Tyrone D CannonDepartment of Psychology, Yale University, New Haven, CT, USA.
Carrie E BeardenDepartment of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA, USA.
University of California, Los Angeles · USLoma Linda University · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Neurodevelopment and Psychosis in the 22q11.2 Deletion SyndromeR01MH085953 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BEARDEN, CARRIE E · 2010 to 2020
$6.2M
Integrative Molecular and Phenotype Analysis of 22q11.2 Deletion SyndromeR01MH100900 · NIMH · STANFORD UNIVERSITY · PI HALLMAYER, JOACHIM F · 2013 to 2017
$4.8M
Neurodevelopment and Psychosis in the 22q11.2 Copy Number VariantsR37MH085953 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CARRIE E BEARDEN · 2023 to 2026
$2.9M
1/5 International Consortium on Brain and Behavior in 22q11.2 Deletion SyndromeU01MH101719 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI GUR, RAQUEL E · 2013 to 2016
$2.8M
Neural basis of social cognition deficits in youth with autism and schizophreniaR00MH113820 · NIMH · LOMA LINDA UNIVERSITY · PI NAIR, AARTI · 2020 to 2022
$747k
Microstructural Neuroimaging of Synaptic Pruning and Myelination in Adolescent PsychosisR21MH116433 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KARLSGODT, KATHERINE HELEN · 2019 to 2020
$429k
Neural Basis of Social Cognition Deficits in Youth With Autism and SchizophreniaK99MH113820 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI NAIR, AARTI · 2018 to 2019
$239k
NCATS NIH HHS UL1 TR001863NIH HHS 1U54EB020403-01NIMH NIH HHS 1R01MH100900-01NIMH NIH HHS K99 MH113820NIMH NIH HHS K99MH113820NIMH NIH HHS R00 MH113820NIMH NIH HHS R01MH085953NIMH NIH HHS R21 MH116433NIMH NIH HHS R37 MH085953NIMH NIH HHS U01MH101719
6 · The paper itself

Abstract

background22q11.2 deletion syndrome (22q11DS) is a common recurrent neurogenetic condition associated with elevated risk for developmental neuropsychiatric disorders and intellectual disability. Children and adults with 22q11DS often exhibit marked social impairment as well as neurocognitive deficits, and have elevated rates of both autism spectrum disorder (ASD) and psychosis. However, the relationship between the basic processes of social cognition and cognitive ability has not been well studied in 22q11DS. Here, we examined differences in social cognition in 22q11DS, relative to multiple groups of idiopathic neuropsychiatric disorders, and typically developing healthy controls (HC). Additionally, we examined differences in intellectual functioning and its relationship to social cognitive abilities. Finally, we examined the relationship between social cognitive abilities and real-world social behavior.

methodsWe examined social cognition and intellectual functioning in 273 participants (mean age = 17.74 ± 5.18% female = 44.3%): 50 with 22q11DS, 49 youth with first episode psychosis (FEP), 48 at clinical high-risk (CHR) for psychosis, 24 participants with ASD, and 102 HC. Social cognition was assessed using The Awareness of Social Inference Test (TASIT), while reciprocal social behavior was assessed via parent/caregiver ratings on the Social Responsiveness Scale (SRS). Participants were also administered the Wechsler Abbreviated Scale of Intelligence, 2nd edition (WASI-II) to assess intellectual functioning.

resultsThe 22q11DS group exhibited significantly lower social cognitive abilities compared to CHR, FEP, and HC groups after controlling for intellectual functioning, but not in comparison to the ASD group. Significant positive correlations were found between social cognition, as measured by the TASIT and IQ across groups. In contrast, no significant relationships were found between TASIT and real-world social behavior (SRS) for any group.

conclusionsOur findings indicate social cognitive deficits are more prominent in 22q11DS than idiopathic neuropsychiatric conditions across the age range, even after adjusting for global intellectual function. These results contribute to our understanding of the intellectual and social vulnerabilities of 22q11DS in comparison to idiopathic neuropsychiatric disorders. Our findings of robust associations between intellectual ability and social cognition emphasizes the importance of accounting for neurocognitive deficits in social skills interventions and tailoring these existing treatment models for 22q11DS and other populations with intellectual impairment.

Indexed as

DiGeorge SyndromeSocial CognitionAdolescentAutism Spectrum DisorderChildCognitionFemaleHumansMalePsychotic DisordersYoung Adult22q11.2 deletionAutism spectrum disorderNeurocognitionPsychosisSocial cognition

Identifiers

PMID33863277
PMCPMC8052741
OpenAlexW3120416510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.